BIFIDO Co., Ltd. (KOSDAQ:238200)
South Korea · Delayed Price · Currency is KRW 2,855.00
+55.00 (1.96%)
At close: May 8, 2026
BIFIDO Market Cap
BIFIDO has a market cap or net worth of 24.21 billion as of May 11, 2026. Its market cap has decreased by -6.18% in one year.
Market Cap
24.21B
Enterprise Value
28.80B
Revenue
19.68B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,855.00
Market Cap Chart
Since December 26, 2018, BIFIDO's market cap has decreased from 149.29B to 24.21B, a decrease of -83.78%. That is a compound annual growth rate of -21.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 24.21B | -3.43% |
| Dec 30, 2025 | 25.07B | 4.07% |
| Dec 30, 2024 | 24.09B | -45.16% |
| Dec 28, 2023 | 43.93B | -36.82% |
| Dec 29, 2022 | 69.53B | -22.02% |
| Dec 30, 2021 | 89.16B | -4.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baskhanbio Pharma | 35.06B |
| Seoul Pharma | 31.83B |
| Pharmsville | 27.51B |
| ChoA Pharmaceutical Co., LTD. | 27.42B |
| Daesung Microbiological Labs. | 26.60B |
| Hurum | 26.23B |
| WooGene B&G | 21.55B |
| Union Korea Pharm | 19.70B |